Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas
Open Access
- 29 July 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 13 (10), 1090-1098
- https://doi.org/10.1093/neuonc/nor107
Abstract
Most primary CNS lymphomas (PCNSL) are diffuse large B-cell lymphomas (DLBCL). However, clinical behavior and prognosis differ considerably from those for nodal DLBCL (nDLBCL), and their pathogenesis is still not fully understood. Micro-RNAs (miRNAs) have been associated with cancer development and progression. We investigated a large miRNA panel for differential expression in PCNSL and nDLBCL, to determine new mechanisms potentially involved in PCNSL pathogenesis. Using paraffin-embedded biopsy specimens from 21 HIV-negative patients with newly diagnosed PCNSL (n = 11) and nDLBCL (n= 10), we measured the expression of 365 miRNA species by quantitative real-time PCR using low-density PCR arrays. We found that 18 miRNAs were differentially expressed: median expression levels of 13 miRNAs were 2.1–13.1 times higher in PCNSL, and median expression levels of 5 miRNAs were 2.6–3.3 times higher in nDLBCL. MiRNAs upregulated in PCNSL were associated with the Myc pathway (miR-17-5p, miR-20a, miR-9), with blocking of terminal B-cell differentiation (miR-9, miR-30b/c), or with upregulation by inflammatory cytokines (miR-155). Putative tumor-suppressor miRNAs (miR-199a, miR-214, miR-193b, miR-145) were downregulated in PCNSL. There was no overlap of miRNAs dysregulated in PCNSL with those differentially expressed between immunohistologically defined germinal center B cell–like (GCB) and non-GCB types or, apart from miR-9, with miRNAs known to be overexpressed in human brain. We conclude that PCNSL exhibits a distinct pattern of miRNA expression compared with nDLBCL. This argues for the involvement of different molecular mechanisms in the pathogenesis of these two lymphoma types.Keywords
This publication has 58 references indexed in Scilit:
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasisNature Cell Biology, 2010
- Onco‐miR‐155 targets SHIP1 to promote TNFα‐dependent growth of B cell lymphomasEMBO Molecular Medicine, 2009
- Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytesNature Immunology, 2008
- Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphomaCancer Genetics and Cytogenetics, 2008
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007
- Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphomaInternational Journal of Cancer, 2007
- BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomasThe Journal of Pathology, 2005
- MicroRNA expression profiles classify human cancersNature, 2005
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005